Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 44 min ago
PreprintCC BYmedRxiv

Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia

  1. 1CIDRZ: Center for Infectious Disease Research in Zambia

Abstract

BackgroundSince the COVID-19 pandemic, parental delays and refusals of well-established, safe, and effective childhood vaccinations have contributed to the resurgence of infectious diseases. This raises concerns that COVID-19 vaccine hesitancy may also extend to novel vaccines for children when introduced in the future. This study examined caregivers, who included healthcare workers (HCWs), perceptions of novel vaccinations for children ages 0-17 years old and intentions to vaccinate children and adolescents ages 12-17 years against COVID-19.

MethodsWe conducted a secondary data analysis of a larger cross-sectional survey administered to parents/caregivers of children ages 0-17 years in Lusaka, Zambia, between 13 November and 15 December 2023. Vaccination intention for COVID-19 was specifically focused on caregivers of adolescents ages 12-17 years, following COVID-19 vaccination guidelines during the study. Descriptive statistics were used to explore demographic characteristics, vaccination history, and caregivers COVID-19 vaccination status, along with their childrens routine childhood vaccine histories and perceptions of COVID-19 and novel vaccinations.

ResultsAmong 277 caregivers (66.8% women, median age: 35 years), 93.1% reported that their child had received all recommended routine childhood vaccinations. COVID-19 vaccine uptake was higher among HCWs (68.2% with [≥]2 doses) than among community members (40.8%) and having [≥]2 doses was associated with higher COVID-19 vaccine uptake among their adolescents ages 12-17 years. 58.0% of caregivers indicated that their 12-17 years old adolescents had received at least one COVID-19 vaccine dose. Overall intention to further vaccinate children against COVID-19, especially among those already unvaccinated, remained low, with 24.7% of caregivers reporting no intent to vaccinate their children. Protection from hospitalization and death from malaria, TB, HIV, pneumonia, influenza, and diarrheal diseases were the most cited reason (79.1%) for intention to vaccinate children with novel vaccines for these diseases. The most prominent reasons for reluctance towards future vaccines were the fear of potential side effects (45.5%) and insufficient knowledge about vaccination benefits and risks (31.8%). Caregivers most trusted the Ministry of Health (86.6%) and healthcare professionals (66.8%) as sources of vaccine information.

ConclusionsWhile routine childhood vaccine uptake remained high, acceptance of COVID-19 and future novel vaccines for children was lower and was influenced by caregivers own vaccination status. Targeted and transparent communication through trusted sources such as the Ministry of Health and healthcare professionals may be critical for addressing safety concerns and strengthening confidence in novel childhood vaccines.

Related

  1. Results of integrating recency testing into routine index testing services in Lusaka, Zambia: A mixed effects regression analysis
    Jake M Pry, Shilpa S Iyer, Chilambwe Mwila +12
    PLOS OnePeer-reviewedCC BYFull textMicrobiologyEpidemiology & public healthPLOSEurope PMCPMC
  2. Genotype-specific agreement and accuracy of human papillomavirus DNA detection using AnyplexTM II HPV28 and XpertTM HPV among women with HIV in Lusaka, Zambia: a diagnostic accuracy analysis
    Nathalie Veronica Fernandez Villalobos, Misinzo Moono, John Andoh +8
    IJID RegionsPeer-reviewedCC BY 4.0Full textEpidemiology & public healthPMC
  3. Exploring the role of social networks in shaping STI disclosure among adolescents and young people using a health behavioral model in Lusaka, Zambia.
    G. Witola, S. Inambwae, A. Silumbwe +7
    medRxivPreprintCC BYFull textInfectious diseasemedRxiv
  4. Admission to the kangaroo mother care ward and maternal postpartum depression in Lusaka, Zambia: a randomised controlled trial study protocol
    Albert Manasyan, Jyoti Lakhwani, Herbert Kapesa +6
    BMJ OpenPeer-reviewedCC BY 4.0Full textObstetrics, gynaecology & paediatricsCrossrefPMC
  5. Factors associated with the use of Long Acting Reversible Contraceptives among adolescents at first level hospitals in Lusaka, Zambia.
    I. Ikabongo, S. Macha, B. Vwalika +5
    medRxivPreprintCC BYFull textObstetrics, gynaecology & paediatricsmedRxiv
BibTeX
@misc{nyasa2026childhood,
  title = {{Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia}},
  author = {M. Nyasa and A. Sharma and A. D. Kerkhoff and D. Ngosa and B. Shamoya and K. Sikombe and S. Simbeza and N. Zulu and E. H. Geng and J. M. Pry and N. Tourneau},
  howpublished = {medRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.21.26363608},
  url = {https://www.medrxiv.org/content/10.64898/2026.09.21.26363608v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Childhood and adolescent immunisation intentions post-COVID-19 in Lusaka, Zambia
AU  - M. Nyasa
AU  - A. Sharma
AU  - A. D. Kerkhoff
AU  - D. Ngosa
AU  - B. Shamoya
AU  - K. Sikombe
AU  - S. Simbeza
AU  - N. Zulu
AU  - E. H. Geng
AU  - J. M. Pry
AU  - N. Tourneau
PY  - 2026
DA  - 2026/09/21
PB  - medRxiv
DO  - 10.64898/2026.09.21.26363608
UR  - https://www.medrxiv.org/content/10.64898/2026.09.21.26363608v1
AB  - BackgroundSince the COVID-19 pandemic, parental delays and refusals of well-established, safe, and effective childhood vaccinations have contributed to the resurgence of infectious diseases. This raises concerns that COVID-19 vaccine hesitancy may also extend to novel vaccines for children when introduced in the future. This study examined caregivers, who included healthcare workers (HCWs), perceptions of novel vaccinations for children ages 0-17 years old and intentions to vaccinate children and adolescents ages 12-17 years against COVID-19.  MethodsWe conducted a secondary data analysis of a larger cross-sectional survey administered to parents/caregivers of children ages 0-17 years in Lusaka, Zambia, between 13 November and 15 December 2023. Vaccination intention for COVID-19 was specifically focused on caregivers of adolescents ages 12-17 years, following COVID-19 vaccination guidelines during the study. Descriptive statistics were used to explore demographic characteristics, vaccination history, and caregivers COVID-19 vaccination status, along with their childrens routine childhood vaccine histories and perceptions of COVID-19 and novel vaccinations.  ResultsAmong 277 caregivers (66.8% women, median age: 35 years), 93.1% reported that their child had received all recommended routine childhood vaccinations. COVID-19 vaccine uptake was higher among HCWs (68.2% with [≥]2 doses) than among community members (40.8%) and having [≥]2 doses was associated with higher COVID-19 vaccine uptake among their adolescents ages 12-17 years. 58.0% of caregivers indicated that their 12-17 years old adolescents had received at least one COVID-19 vaccine dose. Overall intention to further vaccinate children against COVID-19, especially among those already unvaccinated, remained low, with 24.7% of caregivers reporting no intent to vaccinate their children. Protection from hospitalization and death from malaria, TB, HIV, pneumonia, influenza, and diarrheal diseases were the most cited reason (79.1%) for intention to vaccinate children with novel vaccines for these diseases. The most prominent reasons for reluctance towards future vaccines were the fear of potential side effects (45.5%) and insufficient knowledge about vaccination benefits and risks (31.8%). Caregivers most trusted the Ministry of Health (86.6%) and healthcare professionals (66.8%) as sources of vaccine information.  ConclusionsWhile routine childhood vaccine uptake remained high, acceptance of COVID-19 and future novel vaccines for children was lower and was influenced by caregivers own vaccination status. Targeted and transparent communication through trusted sources such as the Ministry of Health and healthcare professionals may be critical for addressing safety concerns and strengthening confidence in novel childhood vaccines.
ER  -